NCT06002230

Brief Summary

In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to Long-COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2021

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2023

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

10 months

First QC Date

August 18, 2023

Last Update Submit

August 19, 2023

Conditions

Adjustment Reaction With Physical Symptoms

Keywords

Complementary therapyHomeopathyCOVID-19Long-COVID-19SARS-CoV-2

Outcome Measures

Primary Outcomes (1)

  • Modified Naranjo criteria

    10 Naranjo criteria are evaluated, eight points is assumed as the limit for potential correlation between homeopathic therapy and amelioration of the symptoms or healing in chronic cases.

    3 days

Study Arms (1)

Patients treated with individualized homeopathy

Patients suffering from symptoms of Long COVID-19 were treated with individualized homeopathy.

Drug: Homeopathic medicines

Interventions

Homeopathic medicinesDRUG

Globules were administered orally..

Also known as: Homeopathic medicinal products
Patients treated with individualized homeopathy

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients suffering from Long COVID-19 symptoms following recovery from SARS-CoV-2 infection.

You may qualify if:

  • Long COVID-19 symptoms following recovery from SARS-CoV-2 infection

You may not qualify if:

  • Patients not signing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sigmund Freud Private University

Vienna, 1020, Austria

Location

MeSH Terms

Conditions

COVID-19Post-Acute COVID-19 Syndrome

Interventions

Homeopathy

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Michael Frass, MD

    Institute for Homeopathic Research

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

August 18, 2023

First Posted

August 21, 2023

Study Start

January 5, 2021

Primary Completion

October 19, 2021

Study Completion

August 10, 2023

Last Updated

August 22, 2023

Record last verified: 2023-08

Locations

AU(1)